tiprankstipranks
Trending News
More News >
Atara Biotherapeutics Appoints New Board Members Amid Restructuring
PremiumCompany AnnouncementsAtara Biotherapeutics Appoints New Board Members Amid Restructuring
1M ago
Atara Biotherapeutics Announces Major Workforce Reduction
Premium
Company Announcements
Atara Biotherapeutics Announces Major Workforce Reduction
2M ago
FDA Lifts Hold on Atara’s EBVALLO Program
Premium
Company Announcements
FDA Lifts Hold on Atara’s EBVALLO Program
2M ago
Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
PremiumCompany AnnouncementsAtara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
4M ago
Atara Biotherapeutics Reports 2024 Financial Results
Premium
Company Announcements
Atara Biotherapeutics Reports 2024 Financial Results
4M ago
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
Premium
The Fly
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
4M ago
Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219
PremiumThe FlyAtara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219
5M ago
Atara Biotherapeutics price target lowered to $17 from $21 at Canaccord
Premium
The Fly
Atara Biotherapeutics price target lowered to $17 from $21 at Canaccord
5M ago
Atara Biotherapeutics trading resumes
Premium
The Fly
Atara Biotherapeutics trading resumes
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100